161 related articles for article (PubMed ID: 15687516)
1. Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman.
Kwan TH; Tong MK; Siu YP; Leung KT; Lee HK; Yung CY; Au TC
Hong Kong Med J; 2005 Feb; 11(1):45-9. PubMed ID: 15687516
[TBL] [Abstract][Full Text] [Related]
2. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy.
Chacko B; John GT; Balakrishnan N; Kirubakaran MG; Jacob CK
Ren Fail; 2006; 28(2):193-5. PubMed ID: 16538981
[TBL] [Abstract][Full Text] [Related]
3. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure following immunoglobulin therapy.
Ahsan N; Wiegand LA; Abendroth CS; Manning EC
Am J Nephrol; 1996; 16(6):532-6. PubMed ID: 8955767
[TBL] [Abstract][Full Text] [Related]
5. [Renal complications from intravenous immunoglobulins. Role of renal hemodynamic factors].
Poullin P; Moulin B; Ollier J; Benaicha M; Olmer M; Gabriel B
Presse Med; 1995 Mar; 24(9):441-4. PubMed ID: 7746817
[TBL] [Abstract][Full Text] [Related]
6. Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy.
Sati HI; Ahya R; Watson HG
Br J Haematol; 2001 May; 113(2):556-7. PubMed ID: 11380432
[TBL] [Abstract][Full Text] [Related]
7. Acute renal failure after large doses of intravenous immune globulin.
Haskin JA; Warner DJ; Blank DU
Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin-induced osmotic nephrosis.
Ahsan N; Palmer BF; Wheeler D; Greenlee RG; Toto RD
Arch Intern Med; 1994 Sep; 154(17):1985-7. PubMed ID: 8074604
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
Dantal J
Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
[TBL] [Abstract][Full Text] [Related]
10. [Intravenous immunoglobulins and acute renal failure: mechanism and prevention].
Fakhouri F
Rev Med Interne; 2007 May; 28 Spec No. 1():4-6. PubMed ID: 17768831
[TBL] [Abstract][Full Text] [Related]
11. Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.
Metallidis S; Papaioannou M; Bokolas G; Kollaras P; Gogou V; Nikolaidis P
Clin Nephrol; 2009 Feb; 71(2):196-7. PubMed ID: 19203515
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin: adverse effects and safe administration.
Orbach H; Katz U; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):173-84. PubMed ID: 16391392
[TBL] [Abstract][Full Text] [Related]
13. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
14. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes.
Dickenmann M; Oettl T; Mihatsch MJ
Am J Kidney Dis; 2008 Mar; 51(3):491-503. PubMed ID: 18295066
[TBL] [Abstract][Full Text] [Related]
15. [Acute renal failure following treatment with intravenously administered immunoglobulins].
van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
[TBL] [Abstract][Full Text] [Related]
16. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
Winward DB; Brophy MT
Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
[TBL] [Abstract][Full Text] [Related]
17. [Acute renal failure after polyvalent immunoglobulin therapy].
Dilhuydy MS; Delclaux C; De Precigout V; Haramburu F; Roger I; Deminière C; Mercié P; Pellegrin JL; Aparicio M
Presse Med; 2000 May; 29(17):942-3. PubMed ID: 10855243
[TBL] [Abstract][Full Text] [Related]
18. [Acute renal insufficiency and cerebral infarction during high-dose intravenous immunoglobulin therapy].
Chatot-Henry C; Smadja D; Mehdaoui H; Fournerie P; Drault JN; Brébion A; Sobesky G
Rev Med Interne; 1998 Dec; 19(12):914-6. PubMed ID: 9887459
[TBL] [Abstract][Full Text] [Related]
19. [Acute kidney failure secondary to intravenous immunoglobulin administration. 4 cases and review of the literature].
Decocq G; de Cagny B; Andréjak M; Desablens B
Therapie; 1996; 51(5):516-26. PubMed ID: 9138386
[TBL] [Abstract][Full Text] [Related]
20. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis.
Hansen-Schmidt S; Silomon J; Keller F
Am J Kidney Dis; 1996 Sep; 28(3):451-3. PubMed ID: 8804246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
